Orange Book product · Generic (ANDA)
PANIXINE DISPERDOSE
CEPHALEXIN
At a glance
Sep 11, 2003
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 11, 2003
23 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
CEPHALEXIN
Strength
EQ 125MG BASE
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
TE code
Not listed
Application
ANDA 065100
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CEPHALEXIN
- —KEFLEXBrand (NDA)
NDA 050405 · PRAGMA
- —KEFLEXBrand (NDA)
NDA 050406 · PRAGMA
- 2026CEPHALEXINGeneric (ANDA)
ANDA 213568 · AUROBINDO PHARMA
- 2024CEPHALEXINGeneric (ANDA)
ANDA 218947 · ALKEM LABS LTD
- 2024CEPHALEXINGeneric (ANDA)
ANDA 218817 · AUROBINDO PHARMA LTD
- 2019CEPHALEXINGeneric (ANDA)
ANDA 210221 · ALKEM LABS LTD
- 2010CEPHALEXINGeneric (ANDA)
ANDA 090836 · ALKEM LABS LTD
- 2009CEPHALEXINGeneric (ANDA)
ANDA 065444 · HIKMA PHARMS
- 2007CEPHALEXINGeneric (ANDA)
ANDA 065336 · YUNG SHIN PHARM
- 2006CEPHALEXINGeneric (ANDA)
ANDA 065326 · CHARTWELL RX
- 2006CEPHALEXINGeneric (ANDA)
ANDA 065215 · HIKMA
- 2005CEPHALEXINGeneric (ANDA)
ANDA 065229 · LUPIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
